Background
The role of contrast enhanced cardiac MRI (ceMRI) in predicting recovery of left ventricular dysfunction is evolving; yet transthoracic echocardiography (TTE) has not been evaluated in this manner.
Methods
Patients with acute ST-elevation MI (STEMI) admitted to Mayo Clinic from August, 2007 to September, 2008 who received reperfusion therapy were screened with TTE and ceMRI. Patients with ceMRI evidence of a previous MI were excluded. Left ventricular dysfunction was defined as an ejection fraction (LVEF) < 50%.
Results
Of 116 patients screened, 91 met inclusion criteria and 56 patients completed follow-up imaging (3-79 weeks). 89% of both the imaging studies were completed within 3 days of the index MI and 32 (57%) patients had a baseline LVEF <50%. The ability of ceMRI and TTE variables to predict normalization of LVEF was assessed using ROC analysis. Delayed enhancement left ventricular mass index (DEi) (DEi <20% 35/56 (63%) was the strongest (AUC 0.86, p=0.0004) predictor of LVEF recovery with a sensitivity, specificity, positive predictive value, and negative predictive value of 0.79, 0.92, 0.94, and 0.75 respectively. When combined with DEi, wall motion score index (WMSI) significantly correlated with follow-up EF (r=0.81, p<0.0001) and overall change in EF (r=0.73, p<0.001). Acute measures of diastolic function did not meaningfully predict LVEF recovery.
Conclusions
A DEi of <20%, as assessed by ceMRI, is the strongest predictor of LVEF normalization in patients with acute post-STEMI left ventricular dysfunction. As compared with TTE, ceMRI provides uniquely valuable information for the long-term management of post-STEMI patients.
